Upper Tract Tumors - Results from #1060

Relationship between aberrant methylation of FAS promoter and biological behavior of bladder urothelial carcinoma - Abstract January 31, 2012

Relative efficacy of perioperative gemcitabine and cisplatin versus methotrexate, vinblastine, adriamycin, and cisplatin in the management of locally advanced urothelial carcinoma of the bladder - Abstract January 26, 2012

Molecular biomarkers in urothelial carcinoma of the bladder: Are we there yet? - Abstract January 25, 2012

Conditional survival of patients with urothelial carcinoma of the urinary bladder treated with radical cystectomy - Abstract January 25, 2012

Experience with gemcitabine monotherapy in three patients with metastatic urothelial carcinoma - Abstract January 24, 2012

Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: A homogeneous series without perioperative chemotherapy - Abstract January 23, 2012

Urothelial carcinoma of the urinary bladder in young adults: Presentation, clinical behavior and outcome - Abstract January 18, 2012

HER2 status in primary stage T1 urothelial cell carcinoma of the urinary bladder - Abstract January 16, 2012

Efficacy of instillations with chemotherapy or immunotherapy following endoscopic resection for upper tract urothelial carcinoma - Abstract January 13, 2012

Urothelial cancers: Using biology to improve outcomes - Abstract January 13, 2012

Impact of the CKD-EPI equation for estimating renal function on eligibility for cisplatin-based chemotherapy in patients with urothelial cancer - Abstract January 9, 2012

Global gene expression changes in human urothelial cells exposed to low-level monomethylarsonous acid - Abstract January 6, 2012

Update on chemotherapy in the treatment of urothelial carcinoma - Abstract January 6, 2012

Nuclear hormone receptor signals as new therapeutic targets for urothelial carcinoma - Abstract January 4, 2012

Different HER2 protein expression profiles aid in the histologic differential diagnosis between urothelial carcinoma in situ (CIS) and non-CIS conditions (dysplasia and reactive atypia) of the urinary bladder mucosa - Abstract December 19, 2011

Metachronous urothelial cancer in bilateral upper urinary tracts and bladder associated with hereditary nonpolyposis colorectal cancer - Abstract December 16, 2011

Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a - Abstract November 29, 2011

Desmocollin 2 is a new immunohistochemical marker indicative of squamous differentiation in urothelial carcinoma - Abstract November 11, 2011

High-grade invasive urothelial carcinoma with focal plasmacytoid differentiation successfully treated by transurethral resection followed by chemoradiotherapy - Abstract November 9, 2011

Urothelial carcinoma of the bladder: Definition, treatment and future efforts - Abstract November 2, 2011

Page 54 of 58